Revenue: The sum of all revenue fields included for a company's operating activities.
DiaMedica Therapeutics, Inc. (DMAC) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-24.44M |
|
-- |
|
-- |
|
$26.68M |
|
$-26.68M |
|
$2.27M |
|
$-24.41M |
|
$-24.41M |
|
$-24.44M |
|
$-24.44M |
|
$-24.44M |
|
$-24.44M |
|
$-26.68M |
|
$-27.98M |
|
40.41M |
|
40.41M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$44.61M |
|
$0.15M |
|
$1.74M |
|
$46.34M |
|
$5.39M |
|
$0.01M |
|
$0.24M |
|
$5.63M |
|
$40.72M |
|
$40.72M |
|
$40.72M |
|
42.82M |
|
| Cash Flow Statement Financials | |
$-22.08M |
|
$8.56M |
|
$11.99M |
|
$4.54M |
|
$3.02M |
|
$-1.52M |
|
$2.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.28 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-60.03% |
|
-60.03% |
|
-52.74% |
|
-60.01% |
|
$0.95 |
|
$-0.55 |
|
$-0.55 |
|